We are live on ! Find out more
OGEN icon

Oragenics

17 hedge funds and large institutions have $57.2K invested in Oragenics in 2025 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 4

0.02% less ownership

Funds ownership: 0.06%0.04% (-0.02%)

6% less funds holding

Funds holding: 1817 (-1)

33% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 3

33% less capital invested

Capital invested by funds: $86K → $57.2K (-$28.8K)

Holders
17
Holders Change
-1
Holders Change %
-5.56%
% of All Funds
0.23%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
5
Reduced
4
Closed
3
Calls
Puts
Net Calls
Net Calls Change

OGEN Hedge Fund Activity: Q1 2025 in Review

17 of the 7,470 institutional investors tracked by Wall St. Rank reported a position in Oragenics (OGEN) for Q1 2025, worth a combined $57.2K — down 33% from $86K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of OGEN and 2 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 5 added.

The largest buyer was Geode Capital Management, adding an estimated $13.4K. The largest seller was HRT Financial, exiting entirely with an estimated $6K sold.

  • 17 institutional investors held Oragenics (OGEN) as of Q1 2025, down from 18 in Q4 2024.
  • Funds reported $57.2K of Oragenics stock for Q1 2025, down 33% quarter-over-quarter.
  • 2 funds opened new Oragenics positions in Q1 2025 and 3 closed out, a net change of -1 holder.
  • The largest Oragenics buyer in Q1 2025 was Geode Capital Management, an estimated $13.4K added.
  • The largest Oragenics seller in Q1 2025 was HRT Financial, an estimated $6K sold.

Based on aggregated 13F filings for Q1 2025.